EarningsQ2 2024 Earnings Report

Epigenomics (ECX) Q2 2024 Earnings Report

1 Followers

DE:ECX Q2 2024 EPS Results

Actual EPS-€0.89

Consensus EPS―

Beat/Miss―

One Year Ago EPS-€3.03

Actual Revenue€0.00

Expected Revenue―

Beat/Miss―

YoY Revenue Growth-100.00%

QuarterQ2 2024

Date07/22/2024

TimeDuring Market Hours

Conference CallMonday, July 22, 2024

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Aug 12, 2026	2026 (Q2)	- / -0.14	-0.228	37.28% (+0.09)
Aug 06, 2025	2025 (Q2)	- / -0.23	-0.91	74.40% (+0.68)
May 07, 2025	2025 (Q1)	- / -2.92	―	―
Mar 20, 2025	2024 (Q4)	- / -	―	―
Nov 06, 2024	2024 (Q3)	- / -	―	―
Jul 22, 2024	2024 (Q2)	- / -0.89	-3.03	70.53% (+2.14)
May 08, 2024	2024 (Q1)	- / -	―	―
Mar 14, 2024	2023 (Q4)	- / -	-7.948	―
Nov 09, 2023	2023 (Q3)	- / -	-0.095	―
Aug 10, 2023	2023 (Q2)	- / -3.03	-1.562	-93.98% (-1.47)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed